Home LiteratureArticle Details
PMID: 19553319 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis.

Journal of virology ·Vol. 83 ·No. 17 ·2009-09-00 ·Pages 8492-501

Rossetto C, Yamboliev I, Pari GS

Abstract

The original cotransfection replication assay identified eight human herpesvirus 8 (HHV8)-encoded proteins required for origin-dependent lytic DNA replication. Previously, we demonstrated that under conditions where K-Rta is overexpressed, a K-bZIP knockout bacmid displayed an aberrant subcellular localization pattern for the latency-associated nuclear protein (LANA). Additionally, these same studies demonstrated that K-bZIP interacts with LANA in the absence of K-Rta and that K-bZIP does not directly participate in, but may facilitate, the initiation of lytic DNA synthesis. We developed a modification of the transient cotransfection replication assay wherein both lytic (oriLyt) and latent (terminal repeat) DNA replication are evaluated simultaneously. We now show that LANA represses origin-dependent lytic DNA replication in a dose dependent manner when added to the cotransfection replication assay. This repression was overcome by increasing amounts of a K-bZIP expression plasmid in the cotransfection mixture or by dominant-negative inhibition of the interaction of LANA with K-bZIP by the overexpression of the K-bZIP-LANA binding domain. Chromatin immunoprecipitation assays show that LANA interacts with oriLyt in the absence of K-bZIP expression, suggesting that suppression of lytic replication by LANA is mediated by direct binding. The interaction of K-bZIP with oriLyt was dependent upon the expression of LANA; however, LANA interacted with oriLyt independently of K-bZIP expression. These data suggest that the interaction of LANA with K-bZIP modulates lytic and latent replication and that K-bZIP facilitates lytic DNA replication and modulates the switch from the latent phase of the virus.

MeSH Terms
Antigens, Viral/metabolism Basic-Leucine Zipper Transcription Factors/metabolism Cell Line Chromatin Immunoprecipitation/methods Cyclins/metabolism DNA, Viral/biosynthesis Gene Expression Regulation, Viral Herpesvirus 8, Human/physiology Humans Nuclear Proteins/metabolism Protein Binding Transfection/methods Viral Proteins/metabolism Virus Replication
Chemicals
Antigens, Viral Basic-Leucine Zipper Transcription Factors Cyclins DNA, Viral K cyclin protein, Herpesvirus 8, Human Nuclear Proteins Viral Proteins latency-associated nuclear antigen
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rossetto Cyprian
Department of Microbiology and Immunology and the Cell and Molecular Biology Graduate Program, University of Nevada-Reno, Reno, Nevada 89557, USA.
Yamboliev Irena
Pari Gregory S
References (33)
33 references, click to expand
  1. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
    Science. 1999 Apr 23;284(5414):641-4 PMID: 10213686
  2. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication.
    J Virol. 2002 Aug;76(15):7890-6 PMID: 12097603
  3. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
    J Hum Virol. 1997 Nov-Dec;1(1):19-29 PMID: 10195227
  4. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.
    Virology. 2008 Sep 30;379(2):234-44 PMID: 18684478
  5. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.
    Cell Cycle. 2006 May;5(10):1048-52 PMID: 16721045
  6. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    J Virol. 2001 Jan;75(1):458-68 PMID: 11119614
  7. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    J Biol Chem. 2001 Aug 17;276(33):31016-22 PMID: 11425857
  8. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    J Virol. 2004 Jun;78(12):6585-94 PMID: 15163750
  9. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.
    J Virol. 2002 Oct;76(20):10320-31 PMID: 12239308
  10. The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.
    Viral Immunol. 2001;14(4):311-7 PMID: 11792061
  11. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    J Virol. 2001 Sep;75(18):8761-71 PMID: 11507221
  12. Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    J Biol Chem. 2004 Apr 16;279(16):16822-31 PMID: 14742422
  13. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
    Virology. 2001 Dec 20;291(2):241-59 PMID: 11878894
  14. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.
    J Virol. 2009 Jun;83(11):5869-80 PMID: 19321621
  15. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.
    J Virol. 2001 Apr;75(7):3250-8 PMID: 11238851
  16. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    J Virol. 2005 Jun;79(12):7453-65 PMID: 15919901
  17. Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication.
    J Biol Chem. 2002 Jul 26;277(30):27401-11 PMID: 12015325
  18. Structure and function of latency-associated nuclear antigen.
    Curr Top Microbiol Immunol. 2007;312:101-36 PMID: 17089795
  19. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
    J Virol. 2003 Aug;77(16):8893-914 PMID: 12885907
  20. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.
    Blood. 2005 Mar 15;105(6):2510-8 PMID: 15572586
  21. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    J Virol. 2004 Apr;78(7):3601-20 PMID: 15016882
  22. The KSHV latency-associated nuclear antigen: a multifunctional protein.
    Front Biosci. 2002 Mar 01;7:d726-30 PMID: 11861213
  23. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids.
    J Virol. 2003 Feb;77(4):2779-83 PMID: 12552022
  24. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    J Virol. 2001 Oct;75(19):9446-57 PMID: 11533207
  25. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    Virology. 2004 Jan 20;318(2):542-55 PMID: 14972523
  26. Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.
    J Virol. 2007 Dec;81(24):13519-32 PMID: 17913803
  27. Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein.
    J Gen Virol. 2001 Mar;82(Pt 3):507-512 PMID: 11172091
  28. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    J Virol. 2002 Nov;76(22):11677-87 PMID: 12388727
  29. Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.
    J Virol. 2000 Sep;74(18):8532-40 PMID: 10954554
  30. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
    J Virol. 2005 Mar;79(6):3479-87 PMID: 15731242
  31. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    N Engl J Med. 1996 Jul 25;335(4):233-41 PMID: 8657239
  32. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
    Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862-7 PMID: 8962146
  33. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
    Science. 1994 Dec 16;266(5192):1865-9 PMID: 7997879
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
1098-5514
Published
2009-09-00
Epub
2009-00-24
Pages
8492-501
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC2738207
Subset
IM
Grants
NCI NIH HHS · CA11521179 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com